Active13747003Private limited companyPetersfield

CORAM PHARMA LIMITED

Significant control: Ian Jacobson (25–50%)

Companies HouseCompanies House

From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms

Coming soon · product and service lists

What does Coram Pharma Limited sell?

Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.

One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01

Summary

Generated from filed data · no estimates

CORAM PHARMA LIMITED is an active private limited company (company number 13747003) incorporated on 16 November 2021, registered in Petersfield. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 31 December 2024 and cash of £227k, with 0 employees on average.

There are 54 companies in research and experimental development on biotechnology in Surrey with filed accounts; the median reports net assets of £1,000 and is 11 years old.

02

Ownership and control

1 active
  • Mr Ian Jacobson
    Individual · since 16 November 2021
    • owns 25–50% of shares
    • holds 25–50% of voting rights

Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.

03

Key dates

Incorporated
16 November 20214 yrs ago
Next accounts due
30 September 202623 days overdue
Confirmation statement due
30 November 2026in 38 days

Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.

04

Activity

SIC 72110
Research and experimental development on biotechnology
Accounts type
Total Exemption Full
Size band
MicroCompanies Act thresholds
05

Financials

2 periods on record · latest ending 31 December 2024
Net assets
Not reported
Cash at bank
£227k
−43%vs Dec 2023
Turnover
Not reported
Employees
0
vs Dec 2023
Cash at bank
£227k
Filed accounts by period, newest first
Period endNet assetsCashDebtorsCreditors <1yTurnoverProfitEmployees
31 December 2024—£227k£54k£32k——0
31 December 2023—£395k£54k£936k——0
Current ratio8.9Current assets ÷ creditors within one year

Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.

06

Filing and accounts signals

Facts from the register · no rating
  • Current assets at least 1.5× creditors within one yearCurrent ratio 8.9
  • Cash at bank of £50,000 or moreCash £226,630
  • Incorporated two to five years agoIncorporated 16 November 2021
  • Accounts past their due dateDue 30 September 2026

Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.

07

Timeline

Newest first
  1. Confirmation statement duein 38 days
  2. Next accounts due23 days overdue
  3. Accounts period end
  4. Accounts period end
  5. Incorporated
08

Similar companies in Surrey

Same activity (research and experimental development on biotechnology), closest in incorporation date
09

Reminders for CORAM PHARMA LIMITED

Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.

Source: Companies House register, snapshot 2026-08-31; accounts from the Companies House accounts data product. Open Government Licence v3.0. View on Companies House. Methodology · About · Markdown.